Allergic rhinoconjunctivitis is common, impacts significantly on the quality of life of the sufferer and is responsible for an enormous economic burden. Symptoms may occur all year round or seasonally, or have seasonal flares depending on the allergen causing the symptoms.
- Allergic rhinoconjunctivitis is common and needs to be distinguished from nonallergic rhinitis.
- The allergen profile in Australia is different from that overseas.
- Regular intranasal corticosteroids are safe and effective if used correctly.
- Immunotherapy is highly efficacious but not a cure.
- Control of allergic rhinoconjunctivitis improves asthma control.
- Sublingual immunotherapy is as effective as subcutaneous immunotherapy.